Last reviewed · How we verify
NCT04013984
Acupuncture for Treatment of Patients With Poor Ovarian Response
NA trial testing Accupuncture in Poor Ovarian Response in 43 participants. Completed in 20 January 2022.
20 January 2021
Quick facts
| Lead sponsor | Royan Institute |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 43 |
| Start date | 1 October 2018 |
| Primary completion | 20 January 2021 |
| Estimated completion | 20 January 2022 |
| Sites | 1 location across Iran |
Drugs / interventions tested
- Accupuncture
Conditions studied
- Poor Ovarian Response — all drugs for Poor Ovarian Response →
- Accupuncture — all drugs for Accupuncture →
Sponsor
Royan Institute
Who can join
Adults 20 to 35, female only, with Poor Ovarian Response or Accupuncture. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This prospective randomized controlled trial is designed to investigate the effect of acupuncture on IVF/ICSI outcome in women with poor ovarian response. The study population consisted of all infertile women with a previous poor ovarian response who will undergo IVF/ICSI in Reproductive Biomedicine Research Center, Royan institute, Tehran Iran. To minimize the effect of ovarian stimulation protocol, a stratified randomization method according to ovarian stimulation protocols (GnRH agonist stopped and GnRH antagonist) is used.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT04013984
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Accupuncture
Trials testing the same drug.
- NCT07335237 — Clinical Study on the Prevention and Treatment of Postoperative Gastrointestinal Dysfunction by Acupuncture Under ERAS M · Phase 2 · completed
Other recruiting trials for Poor Ovarian Response
Currently open trials in the same condition.
- NCT06645379 — Application of Platelet-rich Plasma (PRP) in Reproductive Medicine · NA · recruiting
Other Royan Institute trials
Trials by the same sponsor.
- NCT06199024 — Cinnamon and COH in PCOS Women Underdoing IVF/ICSI Cycles · NA · unknown
- NCT06202547 — Intra-ovarian Injection of MSC-EVs in Idiopathic Premature Ovarian Failure · Phase 1, PHASE2 · unknown
- NCT05460858 — NAC Effect on Infertile Women With Endometrioma · Phase 3 · unknown
- NCT04855383 — Intramuscular Injection of Human Chorionic Gonadotropin in Frozen Embryo Transfer Cycles · NA · completed
- NCT04600986 — Repeated Doses of GnRH Agonist as Oocyte Triggering in Antagonist Protocol for Patients With Polycystic Ovary Syndrome · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04013984 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Royan Institute
- Last refreshed: 15 June 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04013984.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing